Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
373 - What is the guideline for a Med Info booth included within the footprint of a commercial booth at conferences?
-
You’ll want to refer to the Innovative Medicines Canada code for best practices relating to activities at conferences. With regards to PAAB (and Health Canada policies such as the Distinction Between Advertising and Other Activities), it is important to keep Med Info separate from drug advertising (as med info may contain off-label content). The simple act of calling a booth “med info” does not necessarily exempt it from the provisions of drug advertising. For instance, linking med info to product promotion can render the med info subject to the advertising provisions. I am unsure how you’d avoid such linkage if the med info booth is within the footprint of a commercial booth for products. You may want to consider making the med info booth within the foot print of a corporate booth which is separate and distinct from booths relating to product promotion.
